Jared T Hagaman1, Ralph J Panos1, Francis X McCormack1, Charuhas V Thakar2, Kathryn A Wikenheiser-Brokamp3, Ralph T Shipley4, Brent W Kinder5. 1. Division of Pulmonary, Critical Care, and Sleep Medicine, University of Cincinnati College of Medicine, Cincinnati, OH. 2. Division of Nephrology and Hypertension, University of Cincinnati College of Medicine, Cincinnati, OH. 3. Department of Pathology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH. 4. Department of Radiology, University of Cincinnati College of Medicine, Cincinnati, OH. 5. Division of Pulmonary, Critical Care, and Sleep Medicine, University of Cincinnati College of Medicine, Cincinnati, OH. Electronic address: brent.kinder@uc.edu.
Abstract
BACKGROUND: Vitamin D is a steroid hormone with pleiotropic effects including immune system modulation, lung tissue remodeling, and bone health. Vitamin D deficiency has been implicated in the development of autoimmune diseases. We sought to evaluate the prevalence of vitamin D deficiency in a cohort of patients with interstitial lung disease (ILD) and hypothesized that vitamin D deficiency would be associated with an underlying connective tissue disease (CTD) and reduced lung function. METHODS: Patients in the University of Cincinnati ILD Center database were evaluated for serum 25-hydroxyvitamin D levels as part of a standardized protocol. Regression analysis evaluated associations between 25-hydroxyvitamin D levels and other variables. RESULTS: One hundred eighteen subjects were included (67 with CTD-ILD, 51 with other forms of ILD). The overall prevalence of vitamin D deficiency and insufficiency in the study population was 38% and 59%, respectively. Those with CTD-ILD were more likely to have vitamin D deficiency (52% vs 20%, P < .0001) and insufficiency (79% vs 31%, P < .0001) than other forms of ILD. Diminished FVC was associated with lower 25-hydroxyvitamin D(3) levels (P = .01). The association between vitamin D insufficiency and CTD-ILD persisted (OR, 11.8; P < .0001) after adjustment for potential confounders. Among subjects with CTD-ILD, reduced 25-hydroxyvitamin D(3) levels were strongly associated with reduced lung function (FVC, P = .015; diffusing capacity for carbon monoxide, P = .004). CONCLUSIONS: There is a high prevalence of vitamin D deficiency in patients with ILD, particularly those with CTD-ILD, and it is associated with reduced lung function. Vitamin D may have a role in the pathogenesis of CTD-ILD.
BACKGROUND:Vitamin D is a steroid hormone with pleiotropic effects including immune system modulation, lung tissue remodeling, and bone health. Vitamin D deficiency has been implicated in the development of autoimmune diseases. We sought to evaluate the prevalence of vitamin D deficiency in a cohort of patients with interstitial lung disease (ILD) and hypothesized that vitamin D deficiency would be associated with an underlying connective tissue disease (CTD) and reduced lung function. METHODS:Patients in the University of Cincinnati ILD Center database were evaluated for serum 25-hydroxyvitamin D levels as part of a standardized protocol. Regression analysis evaluated associations between 25-hydroxyvitamin D levels and other variables. RESULTS: One hundred eighteen subjects were included (67 with CTD-ILD, 51 with other forms of ILD). The overall prevalence of vitamin Ddeficiency and insufficiency in the study population was 38% and 59%, respectively. Those with CTD-ILD were more likely to have vitamin D deficiency (52% vs 20%, P < .0001) and insufficiency (79% vs 31%, P < .0001) than other forms of ILD. Diminished FVC was associated with lower 25-hydroxyvitamin D(3) levels (P = .01). The association between vitamin Dinsufficiency and CTD-ILD persisted (OR, 11.8; P < .0001) after adjustment for potential confounders. Among subjects with CTD-ILD, reduced 25-hydroxyvitamin D(3) levels were strongly associated with reduced lung function (FVC, P = .015; diffusing capacity for carbon monoxide, P = .004). CONCLUSIONS: There is a high prevalence of vitamin D deficiency in patients with ILD, particularly those with CTD-ILD, and it is associated with reduced lung function. Vitamin D may have a role in the pathogenesis of CTD-ILD.
Authors: E Rand Sutherland; Elena Goleva; Leisa P Jackson; Allen D Stevens; Donald Y M Leung Journal: Am J Respir Crit Care Med Date: 2010-01-14 Impact factor: 21.405
Authors: Hui Chen; Xinxin Chen; Jianfeng Chen; Hong Zhao; Bin Wang; Wei Zheng; Juanjuan Lü; Jiang Du Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2019-07-30
Authors: Avelino C Verceles; Bethany Weiler; Dafna Koldobskiy; Andrew P Goldberg; Giora Netzer; John D Sorkin Journal: Respir Care Date: 2015-02-24 Impact factor: 2.258
Authors: Samuel M Kim; Di Zhao; Anna J Podolanczuk; Pamela L Lutsey; Eliseo Guallar; Steven M Kawut; R Graham Barr; Ian H de Boer; Bryan R Kestenbaum; David J Lederer; Erin D Michos Journal: J Nutr Date: 2018-07-01 Impact factor: 4.798
Authors: Jenny E Han; Jennifer L Jones; Vin Tangpricha; Mona A Brown; Lou Ann S Brown; Li Hao; Gautam Hebbar; Moon Jeong Lee; Shuling Liu; Thomas R Ziegler; Greg S Martin Journal: J Clin Transl Endocrinol Date: 2016-05-05